Retatrutide

DRAGON PHARMA RETATRUTIDE

Retatrutide by Dragon Pharma is a powerful multi-agonist peptide designed to promote fat loss and improve metabolic efficiency. Containing 10 mg of Retatrutide per vial, this advanced peptide targets key metabolic pathways involved in glucose regulation, appetite suppression, and fat burning, making it ideal for athletes and bodybuilders looking to achieve a lean physique. Retatrutide works by stimulating the GLP-1, GIP, and glucagon receptors, enhancing energy metabolism and reducing body fat without compromising muscle mass.

DRUG COMPOSITION

Active substance: Retatrutide (10 mg per vial)
Excipients: Sterile water for injection and stabilizers.

PHARMACEUTICAL FORM

Retatrutide is supplied as a lyophilized powder in 2 mL vials, designed for reconstitution with bacteriostatic water for subcutaneous injection.

PHARMACEUTICAL GROUP AND ATC CODE

Pharmaceutical Group: GLP-1 Receptor Agonist, GIP/Glucagon Receptor Modulator
ATC Code: A10BJ (Drugs used in diabetes).

PHARMACOLOGICAL PROPERTIES

Retatrutide activates GLP-1, GIP, and glucagon receptors, which play crucial roles in regulating appetite, glucose levels, and lipid metabolism. This triple agonist peptide promotes fat oxidation while preventing fat storage, leading to effective weight management. It also improves insulin sensitivity, which enhances energy utilization and metabolic health, making it a valuable tool for those undergoing intense training or cutting phases.

PROFILE

• Chemical name: Retatrutide
• Chemical formula: Not available (multi-agonist peptide)
• Percentage of anabolic activity: None
• Percentage of androgenic activity: None
• Active half life: Approximately 5-7 days
• Recommended dosage: 2.5-15 mg weekly (varies based on clinical protocols and goals)
• Acne: Unlikely
• Bloating (water retention): Minimal
• HBR: Unlikely
• Hepatic toxicity: None
• Aromatization: None

THERAPEUTICAL INDICATIONS

Retatrutide is indicated for:

• Fat loss during cutting phases.
• Improving metabolic health by regulating glucose levels and promoting insulin sensitivity.
• Supporting weight management without compromising muscle mass.

DOSES AND METHOD OF ADMINISTRATION

The recommended dosage of Retatrutide for bodybuilders is 2.5-10 mg per week, administered subcutaneously. A typical cycle lasts 8-12 weeks, with dosage adjusted based on fat loss goals and metabolic response.

CYCLE/STACKING

Retatrutide can be stacked with other Dragon Pharma products to enhance fat loss and metabolic regulation. Example cycles include:

• Cutting Cycle (8-12 weeks):

  • Retatrutide: 5 mg weekly
  • Stack with Clenbuterol for accelerated fat burning and lean muscle retention.
  • Combine with Testosterone Propionate to maintain muscle mass while reducing body fat.

• Recomposition Cycle (8-12 weeks):

  • Retatrutide: 7.5 mg weekly
  • Stack with Anavar for enhanced fat loss and muscle preservation.

POST CYCLE THERAPY

Retatrutide does not suppress natural hormone production, so post-cycle therapy (PCT) is not required. It can be used safely without impacting testosterone levels or requiring hormonal recovery protocols.

SIDE EFFECTS

Common side effects may include mild nausea, gastrointestinal discomfort, or dizziness, particularly at the start of treatment. These symptoms are typically temporary and resolve as the body adjusts to the peptide. Severe side effects are rare but should be reported to a healthcare provider.

CONTRAINDICATIONS

Retatrutide should not be used by individuals with a known hypersensitivity to GLP-1 receptor agonists or any of the product's components. It is also contraindicated for individuals with a history of pancreatitis or severe gastrointestinal disorders. Pregnant or breastfeeding women should avoid using Retatrutide.

OVERDOSE

Overdosing on Retatrutide may result in pronounced gastrointestinal symptoms, such as severe nausea or vomiting. In case of overdose, discontinue use and seek medical attention.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE:

Retatrutide should be used with caution in individuals with a history of gastrointestinal disorders or metabolic issues. It is important to monitor blood glucose levels regularly, especially when using Retatrutide for the first time.

INTERACTIONS WITH OTHER DRUGS

Retatrutide may interact with medications that affect blood sugar levels or gastrointestinal function. Always consult with a healthcare provider before combining Retatrutide with other drugs or supplements.

PRESENTATION, PACKAGING

Retatrutide by Dragon Pharma is packaged in 2 mL vials containing 10 mg of lyophilized Retatrutide. Each vial is securely packaged to ensure product stability and safe delivery.

STORAGE

Store Retatrutide in a cool, dry place away from direct sunlight. Once reconstituted, keep the solution refrigerated and use within 30 days. Keep out of reach of children.

DELIVERY TO THE USA

We offer fast, discreet, and secure delivery of Dragon Pharma Retatrutide to the USA. All orders are packaged with care to ensure product integrity during transit.

LEGAL STATUS

Retatrutide is currently available for research and off-label use in many countries, including the USA. It is not FDA-approved for bodybuilding or weight management, so always check local regulations before purchasing.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Dragon Pharma
Europe

EXTERNAL LINKS

• Retatrutide Wiki, wikipedia.org
• Retatrutide: What is it and is it FDA approved?, drugs.com